Remove 2018 Remove Cannabinoids Remove Data Remove Epilepsy
article thumbnail

Answer of the Day for Jul 20, 2022

TheAnswerPage

Have researchers found that patients who use cannabidiol (CBD)-rich extract therapy for the treatment of epilepsy require a lower dose of CBD medication as compared to those who use purified CBD therapy for the treatment of epilepsy? 12 September 2018. Pamplona F, da Silva L and Coan A. Sec.Neuropharmacology. See the Answer.

article thumbnail

New Study Shows Cannabis Use May Be Responsible For Improved Health And Quality of Life

MedicalJane

A web-based study enrolled 1,276 participants (including those already using a cannabis product and those considering its use) between April 2016 and February 2018. Of the 1,276 participants, 524 adult patients and 284 adult caregivers of children or dependent adults, all self-reported using cannabis for medicinal purposes. Study Findings.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

THC Provides More Symptom Relief Than CBD, According To New Study

MassRoots

Cannabidiol ( CBD ), the non-psychoactive cannabinoid praised for medicinal powers like reducing the severity and frequency of seizures in children suffering from rare and otherwise untreatable forms of epilepsy, may not be the most medically beneficial molecule found in cannabis, according to new data. Data Tracking.

THC 111
article thumbnail

What is CBD? Everything you need to know

The Cannigma

Cannabidiol (CBD) belongs to a class of molecules called cannabinoids , which are produced almost exclusively in cannabis — hence the name. The two cannabinoids can also cause very different effects in other ways. Dr. CBD is also often compared to CBG (cannabigerol) , another increasingly popular cannabinoid. CBD vs CBDA.

CBD 122
article thumbnail

Analysts Envision a $33.2 Billion Medical Cannabis Market By 2027

Veriheal

This is according to recent data from a report published by Market Research Future (MRT) – a pioneer in market analysis. Apart from business leaders, many corporate and government institutions are funding the research and development of cannabinoids for medical applications,” reads an excerpt from the report. Alzheimer’s.

article thumbnail

BBC Report: EU Approves , “Epidyolex” GW Pharmaceuticals

Cannabis Law Report

T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. The medication, developed by GW Pharmaceuticals, will be used in combination with another epilepsy medication called clobazam. What about other medical cannabis products? PDF Version.

article thumbnail

Can cannabis products be used to increase overall health and well-being?

Leaf Science

In spite of this, research has shown that THC as much as the other cannabinoids present in cannabis has medicinal value to humans. In the UK, cannabis was legalized for medicinal purposes in 2018 which saw patients of epilepsy and multiple sclerosis able to access pharmaceutical cannabis derivatives such as Sativex and Epidiolex.

Strains 74